Study suggests stalled amyloid protein production drives Alzheimer's disease
Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.
Alzheimer's Disease Diagnostic Market Growth Forecast At 8.90% CAGR To Hit 8.8 Billion USD By 2032
Alzheimer's disease Diagnostic market Insights: Rising prevalence of Alzheimer's and focus on early diagnosis drive growth.
Outsourcing-pharma1d
Arctic Therapeutics to tackle dementia and skin disease with €26.5 million series A
Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...
Survey shows previous experience affects family planning decisions of people with hereditary dementia
Living in a family where there is genetic risk for dementia significantly affects choices about having children and how to ...
Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing
Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of ...
News Medical on MSN9d
Dementia risk impacts family planning decisions
Living in a family where there is genetic risk for dementia significantly affects choices about having children and how to ...
The Next Web2d
Genomics pioneer steps closer to dementia treatment breakthrough
ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...
ALZFORUM6d
Lactylation—a New Protein Modification That Slows Alzheimer’s?
Lactylation is a reversible, covalent, post-translational modification of proteins. It happens exclusively on lysine residues, where it influences protein structure, stability, localization, and ...